An update on Vitiligo pathogenesis

Julien Seneschal, Katia Boniface, Andrea D’Arino, Mauro Picardo

Research output: Contribution to journalReview articlepeer-review


Vitiligo, the most common depigmenting disorder of the skin, is undergoing a period of intense advances in both disease understanding and therapeutic possibilities leading the way to the beginning of a new era for the disorder. Its pathophysiology has gathered the attention of researchers for years, and many advances have been made in the clarification of the interaction between different factors that result in depigmented macule formation. The complex interplay between non-immunological and immunological factors in vitiligo is key for the development of the disease, and the participation of cells other than melanocytes, such as keratinocytes, fibroblasts, natural killer cells, and innate lymphoid cells, has been shown. Recent advances have also brought to the understanding of the complex part played by a specific subtype of T cells: T-resident memory cells. This review analyzes some of the most recent insights in vitiligo pathogenesis underlining the interactions between different cell types, which are the basis for the therapeutic approaches under development.

Original languageEnglish
JournalPigment Cell and Melanoma Research
Publication statusAccepted/In press - 2020


  • cell–cell cross talk
  • fibroblasts
  • IFN-gamma
  • immunopathogenesis
  • keratinocytes
  • memory T cells

ASJC Scopus subject areas

  • Oncology
  • Biochemistry, Genetics and Molecular Biology(all)
  • Dermatology


Dive into the research topics of 'An update on Vitiligo pathogenesis'. Together they form a unique fingerprint.

Cite this